Clinical Trial Update: MEOI and HRQoL in CLL Patients Treated With BTKis

View source ↗

Summary

A clinical trial evaluating MEOI and health-related quality of life in chronic lymphocytic leukemia patients treated with BTK inhibitors has completed. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• BTK inhibitors (various)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Lymphocytic Leukemia | Status: COMPLETED